Peak Bio, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Peak Bio, Inc. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price of $2.20 per share as of 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice · last filed 2024-11-12
- 2024-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $2.20.
- 2024-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $6.46.
- 2024-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $6.46.
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $5.28.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price |
|---|---|
| 2024-09-30 | $2.20 10-Q · filed 2024-11-12 |
| 2024-06-30 | $6.46 10-Q · filed 2024-08-23 |
| 2024-03-31 | $6.46 10-Q · filed 2024-08-23 |
| 2023-12-31 | $5.28 10-Q · filed 2024-11-12 |
| 2023-09-30 | $5.34 10-Q · filed 2024-06-25 |
| 2023-06-30 | $5.36 10-Q · filed 2023-08-18 |
| 2023-03-31 | $5.36 10-Q · filed 2023-07-12 |
| 2022-12-31 | $5.36 10-K · filed 2024-08-06 |
| 2021-12-31 | $5.04 10-K · filed 2023-06-29 |